Evidence of a role for CD200 in regulation of immune rejection of leukaemic tumour cells in C57BL/6 mice (Q77154302)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11703364%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

title

Evidence of a role for CD200 in regulation of immune rejection of leukaemic tumour cells in C57BL/6 mice (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11703364%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

author name string

R M Gorczynski

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11703364%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

Z Chen

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11703364%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

J Hu

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11703364%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

Y Kai

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11703364%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

J Lei

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11703364%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

publication date

1 November 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11703364%20AND%20SRC:MED&resulttype=core&format=json

Clinical and Experimental Immunology

3 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11703364%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

volume

126

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11703364%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11703364%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

page(s)

220-229

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11703364%20AND%20SRC:MED&resulttype=core&format=json

Allogeneic hematopoietic transplantation as adoptive immunotherapy. Induction of graft-versus-malignancy as primary therapy

3 December 2019

cites work

1 reference

12 December 2020

Function and dysfunction of CD4(+) T cells in the immune response to melanoma

1 reference

12 December 2020

Vaccination with a recombinant vaccinia vaccine containing the B7-1 co-stimulatory molecule causes no significant toxicity and enhances T cell-mediated cytotoxicity

1 reference

12 December 2020

Human Dendritic Cells Transfected with RNA Encoding Prostate-Specific Antigen Stimulate Prostate-Specific CTL Responses In Vitro

1 reference

12 December 2020

Augmentation of antitumor immunity by genetically engineered fibroblast cells to express both B7.1 and interleukin-7

1 reference

12 December 2020

Restoration of alloreactivity of melanoma by transduction with B7.1.

1 reference

12 December 2020

Modulation of the immune response to DNA vaccine by co-delivery of costimulatory molecules

1 reference

12 December 2020

Lymphoid/neuronal cell surface OX2 glycoprotein recognizes a novel receptor on macrophages implicated in the control of their function

1 reference

12 December 2020

Receptor engagement on cells expressing a ligand for the tolerance-inducing molecule OX2 induces an immunoregulatory population that inhibits alloreactivity in vitro and in vivo

1 reference

12 December 2020

Down-regulation of the macrophage lineage through interaction with OX2 (CD200)

1 reference

12 December 2020

Transplant tolerance modifying antibody to CD200 receptor, but not CD200, alters cytokine production profile from stimulated macrophages

1 reference

12 December 2020

Different reticular elements in rat lymphoid tissue identified by localization of Ia, Thy-1 and MRC OX 2 antigens

1 reference

12 December 2020

Specific manipulation in vivo of immunity to skin grafts bearing multiple minor histocompatibility differences

1 reference

12 December 2020

Tumor immunogenicity determines the effect of B7 costimulation on T cell-mediated tumor immunity

1 reference

12 December 2020

Prolongation of rat small bowel or renal allograft survival by pretransplant transfusion and/or by varying the route of allograft venous drainage

1 reference

12 December 2020

B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy

1 reference

12 December 2020

Dependency on intercellular adhesion molecule recognition and local interleukin-2 provision in generation of an in vivo CD8+ T-cell immune response to murine myeloid leukemia

1 reference

12 December 2020

B7-1 and B7-2 do not deliver identical costimulatory signals, since B7-2 but not B7-1 preferentially costimulates the initial production of IL-4.

1 reference

12 December 2020

Gamma delta TCR+ hybridomas derived from mice preimmunized via the portal vein adoptively transfer increased skin allograft survival in vivo

1 reference

12 December 2020

Costimulatory function and expression of CD40 ligand, CD80, and CD86 in vascularized murine cardiac allograft rejection

1 reference

12 December 2020

Graft-versus-leukemia effect and its clinical implications

1 reference

12 December 2020

CD28/B7 interactions are required for sustaining the graft-versus-leukemia effect of delayed post-bone marrow transplantation splenocyte infusion in murine recipients of myeloid or lymphoid leukemia cells

1 reference

12 December 2020

A double recombinant adenovirus expressing the costimulatory molecule B7-1 (murine) and human IL-2 induces complete tumor regression in a murine breast adenocarcinoma model

1 reference

12 December 2020

Tumor antigen presentation: changing the rules

1 reference

12 December 2020

Tumor immunotherapy: cytokines and antigen presentation

1 reference

12 December 2020

Increased expression of the novel molecule OX-2 is involved in prolongation of murine renal allograft survival

1 reference

12 December 2020

Human melanoma cells transfected with the B7-2 co-stimulatory molecule induce tumor-specific CD8+ cytotoxic T lymphocytes in vitro.

1 reference

12 December 2020

The sequence alteration associated with a mutational hotspot in p53 protects cells from lysis by cytotoxic T lymphocytes specific for a flanking peptide epitope

1 reference

12 December 2020

Expression of a type II collagen-specific TCR transgene accelerates the onset of arthritis in mice

1 reference

12 December 2020

Evidence that an OX-2-positive cell can inhibit the stimulation of type 1 cytokine production by bone marrow-derived B7-1 (and B7-2)-positive dendritic cells

1 reference

12 December 2020

Opposing roles of CD28:B7 and CTLA-4:B7 pathways in regulating in vivo alloresponses in murine recipients of MHC disparate T cells

1 reference

12 December 2020

An immunoadhesin incorporating the molecule OX-2 is a potent immunosuppressant that prolongs allo- and xenograft survival

1 reference

12 December 2020

Preparation and functional properties of monoclonal antibodies to human, mouse and rat OX-2.

1 reference

12 December 2020

Tumor's other immune targets: dendritic cells

1 reference

12 December 2020

Gene transfer of the Co-stimulatory molecules B7-1 and B7-2 enhances the immunogenicity of human renal cell carcinoma to a different extent

1 reference

12 December 2020

Tryptophan catabolism and T-cell tolerance: immunosuppression by starvation?

1 reference

12 December 2020

Vaccination with mouse mammary adenocarcinoma cells coexpressing B7-1 (CD80) and B7-2 (CD86) discloses the dominant effect of B7-1 in the induction of antitumor immunity.

1 reference

12 December 2020

10.1046/J.1365-2249.2001.01689.X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11703364%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

0 references

1 reference